Cargando…
Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial
Quitting smoking is the most important element in the therapeutic management of chronic respiratory diseases. Combining pharmacotherapy with behavioral support increases smoking cessation success rates. In addition, hospitalized smokers have increased motivation to quit. We investigated the efficacy...
Autores principales: | Politis, Alexios, Ioannidis, Vasileios, Gourgoulianis, Konstantinos I, Daniil, Zoe, Hatzoglou, Chrissi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958473/ https://www.ncbi.nlm.nih.gov/pubmed/29117796 http://dx.doi.org/10.1177/1479972317740128 |
Ejemplares similares
-
Body Composition in Severe Refractory Asthma: Comparison with COPD Patients and Healthy Smokers
por: Minas, Markos, et al.
Publicado: (2010) -
Effects of smoking cessation on serum leptin and adiponectin levels
por: Kryfti, Maria, et al.
Publicado: (2015) -
COPD patients’ medical care and support in Greece during financial crisis
por: Mitonas, George, et al.
Publicado: (2016) -
Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008) -
Smoking cessation in Asians: focus on varenicline
por: Xiao, Dan, et al.
Publicado: (2015)